Business Standard

Lyka Labs Share Price

Know More
BSENSE

115.20-2.90 (-2.46%)

19th Jul 2024

115.38-2.59 (-2.20%)

19th Jul 2024

BSE : 500259

NSE : LYKALABS

Sector : Health care

ISIN Code : INE933A01014

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 19-Jul-2024

Market Cap (₹ Cr)

411

Traded Value (₹ Cr)

0.23

Volume (Shares)

19,726

Face Value (₹)

10

52-Week High (₹)

143.50

52-Week High Date

24-Nov-2023

52-Week Low (₹)

99.95

52-Week Low Date

04-Jun-2024

All Time High (₹)

267.20

All Time High Date

24-Dec-2021

All Time Low (₹)

8.46

All Time Low Date

07-Aug-2013

Lyka Labs Ltd

Initially manufacturing formulations Lyka Labs brought bulk drugs into its operational fold by amalgamating Lyphin Chemicals Pvt Ltd with itself in Apr. '83. It also added a range of ayurvedic and animal health care products over the years. In 1990 it diversified into marketing medical and diagnostic equipment and instruments of Bekton Dickinson US; Airsep Corporation US; Coloplast Denmark; and Terumo Corporation Japan. Lyka Exports is the subsidiary of the company. The company offers a broad range of antibiotics used as life-savers and to treat minor infections. It has a fairly widespread product base with tropical steroids for skin disorders anti-cancer products cardio-vascular drugs and a...
Read More

Lyka Labs Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

412

EPS - TTM (₹) [C]

0.00

P/E Ratio (X) [C]

-

Face Value (₹) 10
Latest Dividend (%)-
Latest Dividend Date -
Dividend Yield (%) -
Book Value Share (₹) [C]19.82
P/B Ratio (₹) [C]5.82

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Quant Active Fund (G) 8.67 8,41,767 0.21
Quant Active Fund (IDCW) 8.67 8,41,767 0.21
Quant Active Fund - Direct (G) 8.67 8,41,767 0.21
Quant Active Fund - Direct (IDCW) 8.67 8,41,767 0.21

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

112.50

118.52

Week Low/High (₹)

109.99

122.00

Month Low/High (₹)

103.98

122.00

Year Low/High (₹)

97.90

144.00

All time Low/High (₹)

8.46

267.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week2.24%2.39%0.110.12%
1 Month8.64%8.77%4.224.32%
3 Month-10.63%-10.45%10.2810.76%
6 Month-4.25%-4.96%12.4513.45%
1 Year4.51%4.61%20.1323.69%
3 Year91.03%92.46%53.3855.73%

Company Info

Company Information

Chairman & MD & CEO : KUNAL NARENDRA GANDHI

Non-Exec. & Independent Dir. : Sandeep P Parikh

Executive Director & CFO : Yogesh B Shah

Non-Exec. & Independent Dir. : Dhara P. Shah

Company Sec. & Compli. Officer : Kishore P Shah

Independent Director : Babulal Jain

Director : Prashant Godha

Director : Shashil Mendonsa

Registered Office: 4801/B & 4802/A, GIDC Industrial Estate,Ankleshwar,Gujarat-393002 Ph: 91-02646-221422/220549

Email:investorredressal@lykalabs.com; enquiry@lykalabs.c

URL:http://www.lykalabs.com

FAQs about Lyka Labs Ltd

1. What's the Lyka Labs Ltd share price today?
Lyka Labs Ltd share price was Rs 115.20 at close on 19th Jul 2024. Lyka Labs Ltd share price was down by 2.46% from the previous closing price of Rs 118.10. Lyka Labs Ltd share price trend:

  • Last 1 Month: Lyka Labs Ltd share price moved up by 8.64% on BSE
  • Last 3 Months: Lyka Labs Ltd share price moved down by 10.63% on BSE
  • Last 12 Months: Lyka Labs Ltd share price moved up by 4.51% on BSE
  • Last 3 Years: Lyka Labs Ltd price moved up by 91.03% on BSE


2. How can I quickly analyse the performance of the Lyka Labs Ltd stock?
The performance of the Lyka Labs Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is _
  • Price to book value ratio is 5.82
  • Dividend yield of 0.00
  • The EPS (trailing 12 months) of the Lyka Labs Ltd stock is Rs 0.00


3. What is the market cap of Lyka Labs Ltd?
Lyka Labs Ltd has a market capitalisation of Rs 411 crore.


4. What is Lyka Labs Ltd's 52-week high/low share price?
The Lyka Labs Ltd’s 52-week high share price is Rs 143.50 and 52-week low share price is Rs 99.95.


5. Is the Lyka Labs Ltd profitable?
On a consolidated basis, Lyka Labs Ltd reported a loss of Rs -1.62 crore on a total income of Rs 27.37 crore for the quarter ended 2024. For the year ended Mar 2024, Lyka Labs Ltd had posted a loss of Rs -2.13 crore on a total income of Rs 28.08 crore.


6. Which are Lyka Labs Ltd’s peers in the Health care sector?
Lyka Labs Ltd’s top 5 peers in the Health care sector are Venus Remedies, Megasoft, Titan Biotech, Lyka Labs, Zenotech Lab., Fredun Pharma, Jenburkt Pharma.


7. Who owns how much in Lyka Labs Ltd?
Key changes to the Lyka Labs Ltd shareholding are as follows:

  • Promoter holding in Lyka Labs Ltd has gone up to 58.10 per cent as of Jun 2024 from 54.81 per cent as of Dec 2023.